Clinical Trial Update: Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Octanorm for primary immunodeficiency diseases has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disease

Drugs mentioned

• Octanorm

Snippet

Sponsor: Octapharma | Conditions: Primary Immune Deficiency Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-03-10